See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors, 2012 - 2018
Recognized by Best Doctors in America 2009 - 2012, 2015- 2018
Recognized in Philadelphia magazine's Top Docs issues from 2011 - 2013, 2018 - 2020
Perelman Center for Advanced Medicine
Abramson Cancer Center, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Breast cancer geneticsBreast cancer prevention and screeningBreast cancer immunotherapy clinical trials
Nadine M. Tung, MD; Mark E. Robson, MD; Steffen Ventz, PhD; Cesar A. Santa-Maria, MD, MSCI; Rita Nanda, MD; Paul K. Marcom, MD; Payal D. Shah, MD; Tarah J. Ballinger, MD; Eddy S. Yang, MD, PhD; Shaveta Vinayak, MD, MS; Michelle Melisko, MD; Adam Brufsky, MD, PhD; Michelle DeMeo, BS; Colby Jenkins, MS; Susan Domchek, MD; Alan D’Andrea, MD, Nancy U. Lin, MD; Melissa E. Hughes, MS; Lisa A. Carey, MD; Nick Wagle, MD, Gerburg M. Wulf, MD, PhD; Ian E. Krop, MD, PhD, Antonio C. Wolff, MD; Eric P. Winer, MD, and Judy E. Garber, MD, MPH: TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes Journal of Clinical Oncology : 2020.
Pace LE, Lee YS, Tung N, Hamilton JG, Gabriel C, Raja SC, Jenkins C, Braswell A, Domchek SM, Symecko H, Spielman K, Karlan BY, Lester J, Kamara D, Levin J, Morgan K, Offit K, Garber J, Keating NL.: Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial. BMC Med Res Methodol. 20 (1): 210,2020.
Kara N. Maxwell, MD, PhD; Brandon M. Wenz, B; Abha Kulkarni, MPH; Bradley Wubbenhorst, MS; Kurt D’Andrea, BS;Benita Weathers, MPH; Noah Goodman, MPH; Joseph Vijai, PhD; Jenna Lilyquist, PhD, Steven N. Hart, PhD;...Susan M. Domchek, MD; and Katherine L. Nathanson, MD: Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precision Oncology : 2020.
Domchek SM, Postel-Vinay S, Im SA, Park YH, Delord JP, Italiano A, Alexandre J, You B, Bastian S, Krebs MG, Wang D, Waqar SN, Lanasa M, Rhee J, Gao H, Rocher-Ros V, Jones EV, Gulati S, Coenen-Stass A, Kozarewa I, Lai Z, Angell HK, Opincar L, Herbolsheimer P, Kaufman B.: Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA):an open-label, multicentre, phase 1/2, basket study. The Lancet Oncol. : 2020.
Maxwell KN, Wenz BM, Kulkarni A, Wubbenhorst B, D'Andrea K, Weathers B, Goodman N, Vijai J, Lilyquist J, Hart SN, Slavin TP, Schrader KA, Ravichandran V, Thomas T, Hu C, Robson ME, Peterlongo P, Bonanni B, Ford JM, Garber JE, Neuhausen SL, Shah PD, Bradbury AR, DeMichele AM, Offit K, Weitzel JN, Couch FJ, Domchek SM, Nathanson KL.: Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precis Oncol : 2020.
Gallagher S, Hughes E, Wagner S, Tshiaba P, Rosenthal E, Roa BB, Kurian AW, Domchek SM, Garber J, Lancaster J, Weitzel JN, Gutin A, Lanchbury JS, Robson M.: Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- And Moderate-Risk Breast Cancer Genes. JAMA 7 (3): 2020.
Silvestri V, Leslie G, Barnes DR; and the CIMBA Group, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, ...Domchek S...S Hamann U, Greene MH, Kirk JA, Neuhausen SL, Rebbeck TR, Tischkowitz M, Chenevix-Trench G, Antoniou AC, Friedman E, Ottini L.C: Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). JAMA Oncology : 2020.
Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, ...Domchek SM, ...Yannoukakos D, Zimbalatti D, Offit K, Thomassen M, Couch FJ, Schmutzler RK, Simard J, Easton DF, Chenevix-Trench G, Antoniou AC.: Consortium of Investigators of Modifiers of BRCA and BRCA2. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med. : 2020.
Powers J, Pinto EM, Barnoud T, Leung JC, Martynyuk T, Kossenkov AV, Phillips AH, Desai H, Hausler R, ...Domchek SM, ... Couch FJ, Levin B, Edelman MC, Fein Levy C, Spunt SL, Kriwacki RW, Zambetti GP, Ribeiro RC, Murphy ME, Maxwell KN.: A rare TP53 mutation predominant in Ashkenazi Jews confers risk of multiple cancers. Cancer Res. Cancer Res. : 2020.
Shah PD, Domchek SM.: The contemporary landscape of genetic testing and breast cancer: Emerging issues. Breast J. : 2020.
Division of Hematology Oncology10th Floor, South PavilionOffice #10-1503400 Civic Center Boulevard
Patient appointments: 800-789-7366